FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 57 filers reported holding FENNEC PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $68,018 | -11.8% | 9,057 | +3.7% | 0.00% | – |
| Q2 2023 | $77,130 | -2.4% | 8,735 | -31.1% | 0.00% | – |
| Q1 2021 | $79,000 | -16.0% | 12,685 | +0.3% | 0.00% | – |
| Q4 2020 | $94,000 | +20.5% | 12,651 | -1.0% | 0.00% | – |
| Q3 2020 | $78,000 | -29.1% | 12,785 | -3.2% | 0.00% | -100.0% |
| Q2 2020 | $110,000 | +197.3% | 13,210 | +71.3% | 0.00% | – |
| Q1 2019 | $37,000 | -24.5% | 7,710 | +0.9% | 0.00% | – |
| Q4 2018 | $49,000 | -22.2% | 7,639 | -0.8% | 0.00% | – |
| Q3 2018 | $63,000 | -18.2% | 7,697 | +4.3% | 0.00% | – |
| Q2 2018 | $77,000 | – | 7,381 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Solas Capital Management, LLC | 867,857 | $6,327,000 | 4.44% |
| Sonic Fund II, L.P. | 2,433,230 | $17,738,000 | 1.31% |
| DG Capital Management, LLC | 588,773 | $4,292,000 | 0.93% |
| Southpoint Capital Advisors LP | 4,077,214 | $29,723,000 | 0.52% |
| HARBERT FUND ADVISORS, INC. | 120,851 | $881,000 | 0.49% |
| 683 Capital Management, LLC | 1,110,000 | $8,091,000 | 0.28% |
| Avoro Capital Advisors LLC | 1,670,000 | $12,174,000 | 0.21% |
| VALLEY FORGE INVESTMENT CONSULTANTS INC ADV | 40,000 | $292,000 | 0.16% |
| Tibra Equities Europe Ltd | 46,300 | $338,000 | 0.10% |
| GSA CAPITAL PARTNERS LLP | 68,724 | $501,000 | 0.06% |